CLINICAL_TRIALS ClinicalTrials.gov record update

A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05266196
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:02.904075+00:00
Published At: 2023-08-01T00:00:00+00:00
Record Updated At: 2023-08-01
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Ewing Sarcoma", "Myxoid Liposarcoma", "Desmoplastic Small Round Cell Tumor", "Extraskeletal Myxoid Chondrosarcoma", "Angiomatoid Fibrous Histiocytoma", "Clear Cell Sarcoma", "Myoepithelial Tumor", "Low Grade Fibromyxoid Sarcoma", "Sclerosing Epithelioid Fibrosarcoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-08-01"
protocolSection.identificationModule.nctId: "NCT05266196"
protocolSection.identificationModule.officialTitle: "A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.